Pharmacotherapy before and after endovascular intervention in peripheral artery disease

Webinar

Required level of previous knowledge and experience of participants: basic to intermediate

Webinar objectives:

• Explain why it is important to identify patients with peripheral artery disease (PAD) in time and treat them adequately with drugs
• Introduce participants to cardiovascular risk in patients with PAD
• Define groups of drugs that should be prescribed to a patient with PAD for regular use
• Clarify the role of antiplatelet therapy in patients with PAD (in optimal medical therapy, after endovascular intervention and after surgical revascularization)
• Explain new possibilities in antiplatelet treatment of PAD and the impact of new antiplatelet drugs on disease course, cardiovascular and overall mortality
• Inform the participants about the recommendations of the European professional societies on adequate antiplatelet therapy of patients with PAD
• Provide the participants with all the information necessary for independent selection of antiplatelet drugs and their combinations in patients with PAD

Who is the webinar for:

• All physicians involved in the active treatment of patients with peripheral arterial disease: cardiologists, vascular surgeons, interventional radiologists, diabetologists, family physicians and residents in all these specialities.

17:00-17:05	Peripheral artery disease and cardiovascular risk
	Tomislav Krčmar, M.D., Ph.D
17:05-17:25	Drugs that every patient with PAD should have prescribed in therapy
	Prof. Kristina Selthofer-Relatić, M.D., Ph.D.
	Discussion – questions and answers
17:25-17:45	Antiplatelet therapy of patients before and after endovascular interventions in PAD (review of guidelines and COMPASS study)
	Prof. Mislav Vrsalović, M.D., Ph.D.
	Discussion - questions and answers
17:45-18:05	Novelties in antiplatelet therapy after the VOYAGER-PAD study
	Tomislav Krčmar, M.D., Ph.D.
	Discussion - questions and answers
18:05-18:15	Discussion and conclusions